12 Jul VGXI
VGXI is a leading contract manufacturer of DNA-based pharmaceuticals with over 15 years of experience providing exceptional quality GMP products to clinical trials worldwide. The company’s skilled team has an outstanding track record of success in manufacturing challenging plasmid products under GMP conditions with exceptional yield, quality, and prompt delivery. Production services include high purity plasmid DNA preparations for preclinical research, highly documented (HD) plasmid DNA manufacturing for use in GMP viral vector production or pharmacology/toxicology studies, and GMP plasmid DNA for clinical through commercial supply. In addition to standard DNA manufacturing services, VGXI announced the addition of clinical-grade mRNA production services. www.vgxii.com
